DNA Priming for Seasonal Influenza Vaccine: A Phase 1b Double-Blind Randomized Clinical Trial

BACKGROUND: The efficacy of current influenza vaccines is limited in vulnerable populations. DNA vaccines can be produced rapidly, and may offer a potential strategy to improve vaccine immunogenicity, indicated by studies with H5 influenza DNA vaccine prime followed by inactivated vaccine boost. MET...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Ledgerwood, Julie E., Bellamy, Abbie R., Belshe, Robert, Bernstein, David I., Edupuganti, Srilatha, Patel, Shital M., Renehan, Phyllis, Zajdowicz, Thad, Schwartz, Richard, Koup, Richard, Bailer, Robert T., Yamshchikov, Galina V., Enama, Mary E., Sarwar, Uzma, Larkin, Brenda, Graham, Barney S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2015
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423975/
https://ncbi.nlm.nih.gov/pubmed/25950433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0125914
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge